Other News To Note
Inovio Pharmaceuticals Inc., of Blue Bell, Pa., published positive preclinical results for its Chikungunya virus vaccine in PloS Neglected Tropical Diseases. The vaccine protected mice against the virus and induced neutralizing antibodies in mice and nonhuman primates.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.